Isoflavones suppress cyclic adenosine 3',5'-monophosphate regulatory element-mediated transcription in osteoblastic cell line

Journal of Nutritional Biochemistry

Volumn 22, Issue 9, 2011, Pages 865-873

  Tang, Xiaolu ^a   Zhu, Xiaoyan ^a   Liu, Shujuan ^a   Wang, Shan ^a   Ni, Xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cyclic adenosine 3',5' monophosphate regulatory element; Estrogen receptor; Isoflavone; Transcription

Indexed keywords

5,11 DIETHYL 5,6,11,12 TETRAHYDRO 2,8 CHRYSENEDIOL; AFIMOXIFENE; ANTIESTROGEN; CYCLIC AMP; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GENISTEIN; INTERLEUKIN 8; ISOFLAVONE; MESSENGER RNA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BONE REMODELING; CONTROLLED STUDY; CYCLIC AMP RESPONSIVE ELEMENT; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOLYSIS; POSTMENOPAUSE; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REGULATION;

CELL LINE; CHRYSENES; CYCLIC AMP; ESTROGEN RECEPTOR ALPHA; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERLEUKIN-8; ISOFLAVONES; OSTEOBLASTS; PROTEIN-SERINE-THREONINE KINASES; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 80051475546     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.07.011     Document Type: Article

References (45)

1. Riggs B.L., Khosla S., Melton L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23:279-302.
2. Rickard D.J., Subramaniam M., Spelsberg T.C. Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem 1999, 32-33(Suppl):123-132.
3. Chien K.R., Karsenty G. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell 2005, 120:533-544.
4. Riggs B.L., Khosla S., Melton L.J. A unitary model for involutional osteoporosis: estrogen deficiency causes both Type I and Type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998, 13:763-773.
5. Wells G., Tugwell P., Shea B., Guyatt G., Peterson J., Zytaruk N., et al. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002, 23:529-539.
6. Beral V., Banks E., Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002, 360:942-944.
7. Missmer S.A., Eliassen A.H., Barbieri R.L., et al. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004, 96:1856-1865.
8. Sare G.M., Gray L.J., Bath P.M.W. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2008, 29:2031-2041.
9. Jordan V.C., Gapstur S., Morrow M. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. J Natl Cancer Inst 2001, 93:1449-1457.
10. Beck V., Rohr U., Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?. J Steroid Biochem Mol Biol 2005, 94:499-518.
11. Bitto A., Altavilla D., Bonaiuto A., Polito F., Minutoli L., Di Stefano V., et al. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. J Endocrinol 2009, 200:367-376.
12. Marini H., Bitto A., Altavilla D., Burnett B.P., Polito F., Di Stefano V., et al. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study. J Clin Endocrinol Metab 2008, 93:4787-4796.
13. Kanno S., Hirano S., Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 2004, 196:137-145.
14. Yamaguchi M., Weitzmann M.N. The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity. Int J Mol Med 2009, 23:297-301.
15. Chen X., Anderson J.J. Isoflavones and bone: animal and human evidence of efficacy. J Musculoskelet Neuronal Interact 2002, 2:352-359.
16. Yamaguchi M., Sugimoto E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase. Mol Cell Biochem 2000, 214:97-102.
17. O'Malley B.W., Tsai M.J. Molecular pathways of steroid receptor action. Biol Reprod 1992, 46:163-167.
18. Gruber C.J., Gruber D.M., Gruber I.M., Wieser F., Huber J.C. Anatomy of the estrogen response element. Trends Endocrinol Metab 2004, 15:73-78.
19. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 2000, 74:311-317.
20. Nettles K.W., Gil G., Nowak J., Métivier R., Sharma V.B., Greene G.L. CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. Mol Endocrinol 2008, 22:263-272.
21. Castro-Rivera E., Samudio I., Safe S. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 2001, 276:30853-30861.
22. An J., Ribeiro R.C., Webb P., Gustafsson J.A., Kushner P.J., Baxter J.D., et al. Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A 1999, 96:15161-15166.
23. Ni X., Hou Y., King B.R., Tang X., Read M.A., Smith R., et al. Estrogen receptor-mediated down-regulation of corticotropin-releasing hormone gene expression is dependent on a cyclic adenosine 3',5'-monophosphate regulatory element in human placental syncytiotrophoblast cells. J Clin Endocrinol Metab 2004, 89:2312-2318.
24. Dixon R.A. Phytoestrogens. Annu Rev Plant Biol 2004, 55:225-261.
25. Oseni T., Patel R., Pyle J., Jordan V.C. Selective estrogen receptor modulators and phytoestrogens. Planta Med 2008, 74:1656-1665.
26. Tang X., Zhu X., Liu S., Nicholson R.C., Ni X. Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells. Endocrine 2008, 34:29-35.
27. Willard S.T., Frawley L.S. Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells. Endocrine 1998, 8:117-121.
28. Liu D., Jiang H., Grange R.W. Genistein activates the 3',5'-cyclic adenosine monophosphate signaling pathway in vascular endothelial cells and protects endothelial barrier function. Endocrinology 2005, 146:1312-1320.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
30. Pijnenborg R., Luyten C., Vercruysse L., Keith J.C., Van Assche F.A. Cytotoxic effects of tumour necrosis factor (TNF)-alpha and interferon-gamma on cultured human trophoblast are modulated by fibronectin. Mol Hum Reprod 2000, 6:635-641.
31. Iourgenko V., Zhang W., Mickanin C., Daly I., Jiang C., Hexham J.M., et al. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci U S A 2003, 100:12147-12152.
32. Firestone G.L., Giampaolo J.R., O'Keeffe B.A. Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity. Cell Physiol Biochem 2003, 13:1-12.
33. Kim J., Um S.J., Woo J., Kim J.Y., Kim H.A., Jang K.H., et al. Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sci 2005, 78:30-40.
34. Overk C.R., Yao P., Chadwick L.R., Nikolic D., Sun Y., Cuendet M.A., et al. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem 2005, 53:6246-6253.
35. Miller C.P., Collini M.D., Harris H.A. Constrained phytoestrogens and analogues as ERbeta selective ligands. Bioorg Med Chem Lett 2003, 13:2399-2403.
36. Harris D.M., Besselink E., Henning S.M., Go V.L., Heber D. Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 2005, 230:558-568.
37. An J., Tzagarakis-Foster C., Scharschmidt T.C., Lomri N., Leitman D.C. Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 2001, 276:17808-17814.
38. Chang E.C., Charn T.H., Park S.H., Helferich W.G., Komm B., Katzenellenbogen J.A., et al. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol 2008, 22:1032-1043.
39. Mueller S.O., Simon S., Chae K., Metzler M., Korach K.S. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 2004, 80:14-25.
40. Brzezinski A., Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators?. Eur J Obstet Gynecol Reprod Biol 1999, 85:47-51.
41. Riggs B.L., Hartmann L.C. Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 2003, 348:618-629.
42. Pearman A.T., Chou W.Y., Bergman K.D., Pulumati M.R., Partridge N.C. Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE. J Biol Chem 1996, 271:25715-25721.
43. Hai T., Hartman M.G. The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 2001, 273:1-11.
44. Liu B.Y., Wu P.W., Bringhurst F.R., Wang J.T. Estrogen inhibition of PTH-stimulated osteoclast formation and attachment in vitro: involvement of both PKA and PKC. Endocrinology 2002, 143:627-635.
45. Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev 2005, 208:194-206.